← Back to Search

Corticosteroid

Telehealthcare MTM for Asthma (MATCH Trial)

N/A
Recruiting
Led By Kathryn Blake, Pharm.D
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 12 through 35 years
Any activity limitation due to asthma; OR Asthma Control Test score ≤19
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

MATCH Trial Summary

This trial is testing whether using telehealthcare to improve medication adherence will change health outcomes in adolescents and young adults with asthma who have poor adherence with prescribed inhaled corticosteroid therapy.

Who is the study for?
This trial is for young adults aged 12-35 with uncontrolled asthma and poor medication adherence. Participants must have an Asthma Control Test score ≤19 or experience significant symptoms, use a compatible inhaler, speak English or Spanish, and be able to engage in telehealthcare.Check my eligibility
What is being tested?
The MATCH study tests if Telehealthcare Medication Therapy Management (MTM) via video calls and Electronic Adherence Self-Management (EAM) can improve medication adherence in adolescents and young adults with poorly controlled asthma.See study design
What are the potential side effects?
Since the interventions involve management techniques rather than medications, direct side effects are not expected. However, participants may experience discomfort or privacy concerns related to using technology for health monitoring.

MATCH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 35 years old.
Select...
My asthma limits my activities or my Asthma Control Test score is 19 or less.
Select...
I use my rescue inhaler more than twice a week for symptoms.
Select...
My asthma is uncontrolled, showing symptoms or limitations frequently.
Select...
I have been diagnosed with asthma and have no other lung diseases.
Select...
I experience asthma symptoms more than twice a week during the day.
Select...
I have been on inhaled corticosteroids for at least 3 months.
Select...
I use an albuterol inhaler for sudden asthma symptoms.

MATCH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of adherent days as assessed by Propeller sensors
Time (days) to first exacerbation event

MATCH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MTM-EAMExperimental Treatment2 Interventions
Medication Therapy Management Video Telehealthcare plus Electronic Adherence Self-Management [MTM-EAM]
Group II: EAM onlyActive Control1 Intervention
Electronic Adherence Self-Management [EAM] only

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,253 Previous Clinical Trials
14,817,464 Total Patients Enrolled
34 Trials studying Asthma
82,251 Patients Enrolled for Asthma
Nemours Children's Health SystemOTHER
9 Previous Clinical Trials
17,131 Total Patients Enrolled
American Lung AssociationOTHER
31 Previous Clinical Trials
10,673 Total Patients Enrolled
13 Trials studying Asthma
3,099 Patients Enrolled for Asthma

Media Library

Inhaled corticosteroid (ICS) (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT03978936 — N/A
Asthma Research Study Groups: EAM only, MTM-EAM
Asthma Clinical Trial 2023: Inhaled corticosteroid (ICS) Highlights & Side Effects. Trial Name: NCT03978936 — N/A
Inhaled corticosteroid (ICS) (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03978936 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently being accepted for participation in this clinical trial?

"As documented on clinicaltrials.gov, this research trial is actively recruiting with a start date of November 18th 2019 and an edit as recent as August 24th 2022."

Answered by AI

How many participants have been recruited to take part in this research project?

"This medical research requires 300 participants that fulfill the specified criteria. Rush University Medical Centre in Chicago, Illinois and University of Illinois at Chicago in Kansas City, Kansas are two sites where these patients can take part."

Answered by AI

How many locations are involved in the implementation of this clinical trial?

"Patients may register for this trial at Rush University Medical Center in Chicago, Illinois and the University of Illinois at Chicago in Kansas City, Kansas. Moreover, New york's University of Kansas Medical Centre is also participating as one of 23 other recruitment sites."

Answered by AI

Is there a way I can become involved in this experiment?

"This clinical trial seeks out 300 young adults aged 12-35 who have physician diagnosed asthma, suffer from activity limitations due to their condition, need a rescue inhaler more than twice per week, and score greater than 8 on the Adherence to Refills and Medication Scale (ARMS) 7-item questionnaire. Furthermore, they must experience daytime symptoms of asthma more often than not and awaken at night due to their disease."

Answered by AI

Is the age eligibility for this research limited to those over 55 years old?

"This clinical trial has a minimum age of 12 and an upper limit for enrolment set at 35 years old."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
Baylor College of Medicine
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
1
3+

Why did patients apply to this trial?

To find a new way to control my asthma.
PatientReceived 2+ prior treatments
~44 spots leftby Jan 2025